Pruitt Michael D (CIK 0001124144)

Latest company ownership

Shares held
17,256
Last filed at
Mar 24, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2009Q3 2025Q4
Shares held
12,141
Last filed at
Jan 2, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 15, 2025 Forward Industries, Inc. CEO Buy 90.0 +1,000 100.00% ✗ $7.4K
Oct 15, 2022 Oct 20, 2022 IMAC Holdings, Inc. Director Sell 91.3 +63,000 62.22% ✗ $11.5K
Mar 25, 2021 Mar 29, 2021 IMAC Holdings, Inc. Director Buy 85.0 +750 5.77% ✗ $1.2K
Mar 23, 2020 Mar 24, 2020 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 90.0 +7,206 10.84% ✗ $4.1K
Dec 10, 2019 Dec 10, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +200 0.36% ✗ $124.4
Nov 19, 2019 Nov 19, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 82.5 +2,165 3.75% ✗ $1.5K
Aug 23, 2019 Aug 23, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +1,000 1.93% ✗ $572
Aug 19, 2019 Aug 19, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 90.0 +5,000 10.66% ✗ $3.1K
Jul 30, 2019 Jul 31, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +105 0.22% ✗ $117.6
Jun 4, 2019 Jun 4, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 82.5 +1,100 3.04% ✗ $1.1K
May 24, 2019 May 29, 2019 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 82.5 +1,000 2.84% ✗ $1.1K
Dec 31, 2018 Dec 31, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 82.5 +1,000 2.93% ✗ $1.3K
Dec 14, 2018 Dec 17, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +500 1.49% ✗ $1K
Nov 30, 2018 Nov 30, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +500 1.51% ✗ $880
Nov 27, 2018 Nov 28, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 82.5 +1,000 3.11% ✗ $1.8K
Nov 16, 2018 Nov 16, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +400 1.26% ✗ $776
May 8, 2018 May 11, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 85.0 +1,500 5.09% ✗ $5.3K
Mar 30, 2018 Apr 3, 2018 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 91.3 +6,757 29.61% ✗ $25K
Sep 26, 2017 Sep 27, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +100 0.44% ✗ $196
Sep 7, 2017 Sep 7, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +100 0.44% ✗ $224.9
Aug 17, 2017 Aug 17, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 67.5 +150 0.67% ✗ $390
Jun 15, 2017 Jun 15, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +100 0.45% ✗ $267.6
Jun 2, 2017 Jun 2, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +100 0.45% ✗ $275.5
May 17, 2017 May 18, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +5,000 2.31% ✗ $1.7K
Mar 31, 2017 Apr 3, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 77.5 +3,000 1.39% ✗ $1.1K
Jan 3, 2017 Jan 3, 2017 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.14% ✗ $119.9
Dec 29, 2016 Dec 30, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.14% ✗ $129
Dec 21, 2016 Dec 22, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 47.5 +100 0.05% ✗ $1.4K
Dec 21, 2016 Dec 21, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 47.5 +100 0.05% ✗ $1.4K
Nov 28, 2016 Nov 28, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +400 0.19% ✗ $216.8
Nov 16, 2016 Nov 16, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +1,000 0.47% ✗ $548
Sep 28, 2016 Sep 28, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +400 0.19% ✗ $232
Sep 15, 2016 Sep 16, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +800 0.38% ✗ $467.2
Sep 7, 2016 Sep 7, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.24% ✗ $204.9
Aug 22, 2016 Aug 23, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +1,000 0.47% ✗ $389.9
Aug 15, 2016 Aug 16, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +1,000 0.48% ✗ $428.7
Jul 20, 2016 Jul 20, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.24% ✗ $223.5
Jul 5, 2016 Jul 7, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 67.5 +2,000 0.96% ✗ $851.6
Jun 15, 2016 Jun 15, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.24% ✗ $235
Jun 6, 2016 Jun 8, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.24% ✗ $250.5
May 20, 2016 May 23, 2016 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 67.5 +2,000 0.98% ✗ $1.1K
May 28, 2014 May 30, 2014 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.15% ✗ $612
Apr 4, 2013 Apr 5, 2013 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.24% ✗ $880
Jul 21, 2011 Jul 22, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.07% ✗ $897
Jul 5, 2011 Jul 7, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.07% ✗ $897
Jun 28, 2011 Jun 29, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +1,100 0.27% ✗ $2.7K
Jun 27, 2011 Jun 28, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +300 0.07% ✗ $807
Jun 17, 2011 Jun 21, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +300 0.50% ✗ $897
Mar 31, 2011 Apr 1, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 83.8 +14,286 3.68% ✗ $25K
Mar 24, 2011 Mar 28, 2011 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +1,500 0.39% ✗ $4.8K
Oct 28, 2010 Oct 28, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +100 0.05% ✗ $375
Sep 24, 2010 Oct 1, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +150 0.08% ✗ $600
Aug 10, 2010 Aug 12, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.26% ✗ $1.9K
Jun 30, 2010 Jul 6, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 90.0 +16,797 9.56% ✗ $58.8K
Jun 24, 2010 Jun 28, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $1.9K
Jun 11, 2010 Jun 14, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $2.1K
Jun 3, 2010 Jun 7, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $2K
May 17, 2010 May 18, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $2.1K
Apr 28, 2010 Apr 29, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $2K
Apr 23, 2010 Apr 27, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.29% ✗ $1.9K
Apr 12, 2010 Apr 14, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 67.5 +1,000 0.58% ✗ $3.8K
Mar 23, 2010 Mar 24, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +750 0.44% ✗ $2.9K
Mar 15, 2010 Mar 15, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 55.0 +250 0.15% ✗ $1K
Jan 11, 2010 Jan 19, 2010 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +350 0.21% ✗ $1.4K
Dec 4, 2009 Dec 7, 2009 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +750 0.44% ✗ $2.6K
Sep 18, 2009 Sep 22, 2009 Sonnet BioTherapeutics Holdings, Inc. CEO Buy 60.0 +500 0.30% ✗ $1.3K